Invesco Ltd. I Mab Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.58 - $1.9 $42,993 - $51,700	-27,211 Reduced 31.96%	57,933 $96,000
Q1 2024 May 14, 2024	BUY	$1.54 - $2.37 $100,686 - $154,952	65,381 Added 330.83%	85,144 $158,000
Q4 2023 Feb 12, 2024	SELL	$1.21 - $1.9 $77,922 - $122,358	-64,399 Reduced 76.52%	19,763 $37,000
Q3 2023 Nov 13, 2023	BUY	$1.18 - $3.06 $10,885 - $28,228	9,225 Added 12.31%	84,162 $111,000
Q2 2023 Aug 11, 2023	SELL	$2.95 - $3.85 $35,650 - $46,527	-12,085 Reduced 13.89%	74,937 $224,000
Q1 2023 May 12, 2023	BUY	$3.08 - $7.39 $37,197 - $89,249	12,077 Added 16.11%	87,022 $301,000
Q4 2022 Feb 13, 2023	BUY	$3.22 - $4.86 $376 - $568	117 Added 0.16%	74,945 $313,000
Q3 2022 Nov 14, 2022	SELL	$4.01 - $12.34 $8 - $24	-2 Reduced -0.0%	74,828 $300,000
Q2 2022 Aug 15, 2022	BUY	$8.27 - $18.43 $59,701 - $133,046	7,219 Added 10.68%	74,830 $846,000
Q1 2022 May 16, 2022	BUY	$12.54 - $46.93 $323,895 - $1.21 Million	25,829 Added 61.82%	67,611 $1.1 Million
Q4 2021 Feb 14, 2022	BUY	$45.28 - $74.5 $287,165 - $472,479	6,342 Added 17.9%	41,782 $1.98 Million
Q3 2021 Nov 15, 2021	BUY	$57.18 - $84.43 $656,769 - $969,762	11,486 Added 47.95%	35,440 $2.57 Million
Q2 2021 Aug 17, 2021	BUY	$47.86 - $83.95 $381,970 - $670,004	7,981 Added 49.97%	23,954 $2.01 Million
Q1 2021 May 17, 2021	BUY	$44.38 - $63.97 $105,446 - $151,992	2,376 Added 17.47%	15,973 $774,000
Q4 2020 Feb 16, 2021	BUY	$32.94 - $47.15 $209,663 - $300,109	6,365 Added 88.01%	13,597 $641,000
Q3 2020 Nov 16, 2020	BUY	$27.46 - $47.03 $1,482 - $2,539	54 Added 0.75%	7,232 $340,000
Q2 2020 Aug 14, 2020	BUY	$13.0 - $31.0 $93,314 - $222,518	7,178 New	7,178 $215,000

Others Institutions Holding IMAB

# of Institutions

Shares Held

15.5M

Call Options Held

56.4K

Put Options Held

5.8K

Hhlr Advisors, Ltd. Grand Cayman, E9

6.91M
Shares

$6.56 Million
0.2% of portfolio
Decheng Capital Management Iii (Cayman), LLC

4.17M
Shares

$3.96 Million
3.04% of portfolio
Boothbay Fund Management, LLC New York, NY

1.42M
Shares

$1.35 Million
0.05% of portfolio
Temasek Holdings (Private) LTD Singapore, U0

567K
Shares

$538,317
0.0% of portfolio
David A. Siegel Two Sigma Advisers, LP | New York, Ny

499K
Shares

$474,335
0.0% of portfolio

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $78.9M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account